Unified Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$445K Sell
1,926
-28
-1% -$6.91K 0.13% 63
2021
Q2
$448K Hold
1,954
0.13% 61
2021
Q1
$365K Hold
1,954
0.12% 63
2020
Q4
$387K Sell
1,954
-46
-2% -$6.87K 0.22% 47
2020
Q3
$296K Sell
2,000
-400
-17% -$61.9K 0.21% 47
2020
Q2
$394K Hold
2,400
0.3% 45
2020
Q1
$332K Hold
2,400
0.22% 44
2019
Q4
$315K Hold
2,400
0.2% 50
2019
Q3
$268K Sell
2,400
-100
-4% -$11.1K 0.18% 50
2019
Q2
$276K Hold
2,500
0.19% 45
2019
Q1
$324K Hold
2,500
0.24% 42
2018
Q4
$289K Buy
+2,500
New +$279K 0.26% 46

Other funds holding LLY

Unified Trust Company's LLY Position: Q3 2021 in Review

Unified Trust Company reduced its Eli Lilly (LLY) stake by 1.4% in Q3 2021, selling an estimated $6.91K and leaving 1,926 shares worth $445K. The position accounts for 0.13% of the portfolio, ranked #63.

Unified Trust Company first reported a position in LLY in Q4 2018 and has held it in 12 quarters since. The position peaked at $448K in Q2 2021. 2,050 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Unified Trust Company held 1,926 shares of Eli Lilly worth $445K as of Q3 2021.
  • Unified Trust Company sold 28 Eli Lilly shares in Q3 2021, an estimated $6.91K.
  • Eli Lilly made up 0.13% of Unified Trust Company's portfolio in Q3 2021, its #63 holding.
  • Unified Trust Company first reported a position in Eli Lilly in Q4 2018 and has held it in 12 quarters since.
  • Unified Trust Company's Eli Lilly position peaked at $448K in Q2 2021.
  • 2,050 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Unified Trust Company's 13F filing for Q3 2021, filed 23 Nov 2021.